HOME >> MEDICINE >> NEWS
Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders

ST. LOUIS -- Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.

They have shown that a cocktail of ribavirin and Infergen, a highly potent Interferon, is nearly twice as effective at controlling hepatitis C than standard treatments.

They are sharing their findings at the annual American Association for the Study of Liver Diseases meeting in Boston.

"The results are promising," says Bruce R. Bacon, M.D., principal investigator and director of the division of gastroenterology and hepatology at Saint Louis University School of Medicine. "This group of non-responders is a very challenging population to treat, and we found that patients who followed through with the therapy had a response nearly twice that of previous trials looking at this population."

Saint Louis University Liver Center researchers led a study of more than 500 patients with hepatitis C at 40 sites, 77 percent of whom had advanced fibrosis. Fourteen percent of patients taking 9mcg of Infergen daily and 20 percent taking 15 mcg were virus negative after six months.

A quarter of the non-cirrhotic patients receiving Infergen were also virus negative after 24 weeks. The optimal response to antiviral therapy is for the hepatitis C viral RNA to become undetectable on treatment and to remain undetectable for at least another six months off therapy; this is referred to as a sustained virologic response, essentially a cure of the disease. Rates of sustained virologic response are still to be determined in this ongoing study.

Infergen is a highly potent type of interferon currently used for adult patients with chronic hepatitis C three times a week, Bacon says. This trial is expected to be completed in 2007.

An estimated 3.9 million Americans have hepatitis C. About 250,000 who have been offered therapy are
'"/>

Contact: Rachel Otto
ottorl@slu.edu
314-977-8018
Saint Louis University
30-Oct-2006


Page: 1 2

Related medicine news :

1. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
2. Making old hearts young again
3. Making sense of the world through a cochlear implant
4. Making heart surgery intervention safer
5. Making a healthy lunch a greater national priority
6. Making multiple lifestyle changes is beneficial, achievable in lowering high blood pressure
7. Making the most of our precious nursing resources
8. Making the best decisions when faced with the risks of premature delivery
9. Making primary health care work: New research
10. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
11. DNA vaccine against multiple sclerosis appears safe, potentially beneficial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... LONDON (PRWEB) , ... December 05, 2018 , ... ... misdiagnosed and the causes of this condition are poorly understood. It manifests on ... not a life threatening condition, it can cause enormous social and psychological problems. ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
(Date:12/5/2018)... ... December 05, 2018 , ... To change ... Unitek’s transformative conference at the DoubleTree Hilton Hotel in Newark, California. Led by ... and Founder/Director of Watson Caring Science Institute, participants and esteemed guests discussed the ...
(Date:11/29/2018)... ... 2018 , ... The National Association of Chronic Disease Directors ... Preventing Chronic Disease is Essential - Prevention Works ,” to support federal funding ... , The paper outlines some of the strongest public health, economic, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... The Lake Trust Foundation received ... and a razor for distribution to eight Michigan homeless shelters. Lake Trust Credit Union ... or more of the organizations to be selected by the internal Lake Trust Credit ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... Medical Device Cybersecurity Risks ... Webinar**, Tuesday, Dec. 18, 2018, 1:30 p.m. - 3:00 p.m. ET, ... , Cybersecurity is becoming an everyday risk. , FDAnews has reached out ...
(Date:12/5/2018)... Va. (PRWEB) , ... December 05, 2018 , ... ... today that Mary Crivellone, PhD, the former Director of Global Laboratory Integration at ... Consultant. Dr. Crivellone is a Laboratory Operations executive with extensive experience in domestic ...
(Date:11/29/2018)... AUSTIN, Texas (PRWEB) , ... November 29, 2018 ... ... cycle management (RCM) and electronic health records (EHR) technology for acute care, post-acute ... to Vice President of Customer Support and Service. Hynds will lead Cantata Health’s ...
Breaking Medicine Technology:
Cached News: